Streetbeat News

Analyst Ratings

IVZ

RBC Capital analyst Kenneth Lee maintains a Sector Perform rating on Invesco (NYSE:IVZ) and raises the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:00 pm

ADUS

Addus HomeCare (NASDAQ:ADUS) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. Analysts have set a 12-month average price target of $141.56, reflecting a 4.56% increase from the previous target. The company's financial performance shows strong revenue growth and profitability, with a notable net margin and return on equity.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

ADUS

Macquarie analyst Tao Qiu has reiterated an 'Outperform' rating for Addus HomeCare (NASDAQ:ADUS) and maintained a price target of $139.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:59 pm

VCTR

RBC Capital has maintained its 'Outperform' rating on Victory Capital Holdings and increased the price target from $55 to $61.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:58 pm

COLL

Piper Sandler analyst David Amsellem has reiterated a Neutral rating for Collegium Pharmaceutical (NASDAQ:COLL) and maintained a price target of $37.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:58 pm

VOYA

RBC Capital analyst Kenneth Lee maintains an Outperform rating on Voya Financial and raises the price target from $83 to $90.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:56 pm

STRO

Piper Sandler analyst Edward Tenthoff has reiterated an Overweight rating on Sutro Biopharma (NASDAQ:STRO) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:56 pm

GOOG

Scotiabank analyst Nat Schindler initiated coverage on Alphabet Inc. (NASDAQ:GOOG) with a Sector Outperform rating and a price target of $212, citing Google's strong position in AI and resilience to macroeconomic factors. Despite antitrust actions, the outlook remains positive.

Portfolio Pulse from Lekha Gupta

October 11, 2024 | 5:55 pm

CE

RBC Capital analyst Arun Viswanathan maintains an Outperform rating on Celanese (NYSE:CE) but lowers the price target from $167 to $163.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:54 pm

EMN

RBC Capital analyst Arun Viswanathan maintains a Sector Perform rating on Eastman Chemical (NYSE:EMN) and raises the price target from $100 to $107.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:53 pm